Resminostat Completed Phase 1 Trials for Cutaneous T-Cell Lymphoma (CTCL) / Mycosis Fungoides (MF) / Sezary Syndrome Treatment

Indications	Status	Purpose	Phase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL)) DBCOND0057197 (Mycosis Fungoides (MF)) DBCOND0001518 (Sezary Syndrome)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT04955340	A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat	Resminostat (DB12392)